Provided by Tiger Fintech (Singapore) Pte. Ltd.

Xencor

7.98
-0.3400-4.09%
Post-market: 7.980.00000.00%16:41 EDT
Volume:893.16K
Turnover:7.14M
Market Cap:567.94M
PE:-2.62
High:8.59
Open:8.20
Low:7.84
Close:8.32
Loading ...

Xencor Inc. Files Initial Statement of Beneficial Ownership for Director Raymond Joseph Deshaies

Reuters
·
01 Aug

Xencor Appoints Raymond Deshaies to Board of Directors

TIPRANKS
·
01 Aug

Xencor Inc. Appoints Raymond Deshaies, Ph.D., to Board of Directors for Enhanced Scientific Leadership

Reuters
·
01 Aug

Xencor’s Phase 2 Study on Vudalimab in Prostate Cancer: Key Update and Market Impact

TIPRANKS
·
18 Jul

Xencor’s Promising Developments in Autoimmune and Oncology Drive Buy Rating

TIPRANKS
·
25 Jun

Bank of America Securities Sticks to Their Buy Rating for Xencor (XNCR)

TIPRANKS
·
24 Jun

Director Richard J. Ranieri Reports Disposal of Common Shares of Xencor Inc

Reuters
·
17 Jun

Xencor Holds Annual Stockholders Meeting on June 12

TIPRANKS
·
14 Jun

Xencor Inc. Conducted Its Annual Stockholders Meeting

Reuters
·
14 Jun

Xencor Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
09 May

Xencor Is Maintained at Underweight by Barclays

Dow Jones
·
09 May

Xencor’s Promising Pipeline and Strategic Collaborations Justify Buy Rating

TIPRANKS
·
08 May

Xencor Q1 EPS $(0.66) Misses $(0.60) Estimate, Sales $32.73M Beat $22.41M Estimate

Benzinga
·
08 May

BRIEF-Xencor Q1 EPS USD -0.66 Vs. IBES Estimate USD -0.6

Reuters
·
08 May

Top Xencor Executive Cashes In on Stock Sale!

TIPRANKS
·
07 May

EVP and Chief Development Officer Nancy Valente Reports Disposal of Xencor Inc. Common Shares

Reuters
·
07 May

Will Xencor (XNCR) Report Negative Q1 Earnings? What You Should Know

Zacks
·
01 May

Xencor Announces Positive Interim Results From First-in-Human Healthy Volunteer Study of XmAb942, a High-Potency Extended Half-Life Anti-TL1A Antibody, in Development for Treatment of Inflammatory Bowel Disease

Business Wire
·
30 Apr

Xencor Initiated at Outperform by William Blair

Dow Jones
·
21 Apr

William Blair Initiates Xencor at Outperform

MT Newswires Live
·
21 Apr